Can low short-chain fatty acid production impair gut barrier function and reduce thyroid hormone signaling?

The connection between gut microbiota health and thyroid function is increasingly recognized through the "gut-thyroid axis," where short-chain fatty acids (SCFAs) act as primary mediators of systemic inflammatory tone.

Gut barrier and short-chain fatty acids

Short-chain fatty acids, particularly butyrate, are essential for maintaining the physical and immunological integrity of the intestinal lining.

• Mechanistic pathways: Butyrate serves as the primary energy source for colonocytes and enhances the expression of tight junction proteins, including claudin-1, occludin, and zonula occludens-1 (ZO-1), via histone deacetylase (HDAC) inhibition.
• Consequences of depletion: When SCFA production is low, the intestinal barrier becomes compromised, leading to increased paracellular permeability. This allows the translocation of lipopolysaccharides (LPS) and other microbial products into systemic circulation, triggering a state of chronic low-grade inflammation.

Inflammation and thyroid hormone signaling

Systemic inflammation is a well-established driver of Non-Thyroidal Illness Syndrome (NTIS), where thyroid signaling is impaired despite the absence of primary thyroid disease.

• Deiodinase dysregulation: Pro-inflammatory cytokines, specifically IL-6 and TNF-α, directly interfere with thyroid hormone metabolism. These cytokines suppress type 1 deiodinase (DIO1)—the enzyme responsible for converting thyroxine (T4) into the active triiodothyronine (T3)—while simultaneously upregulating type 3 deiodinase (DIO3), which converts T3 into the inactive reverse T3 (rT3).
• Cellular interference: TNF-α has been shown to decrease the activity of the DIO1 gene promoter and inhibit nuclear receptor coactivators, further reducing the sensitivity of peripheral tissues to active thyroid hormones. In aging populations, such as a 70-year-old female, elevated IL-6 levels are frequently correlated with lower serum T3 levels and higher rT3.

Bottom line

Low SCFA production leads to gut barrier dysfunction and systemic inflammation, which suppresses active thyroid hormone production by inhibiting T4-to-T3 conversion and promoting hormone inactivation. Maintaining high fiber intake and a diverse microbiome is critical for preserving thyroid signaling during chronic illness.